1. Home
  2. ARMP vs AUID Comparison

ARMP vs AUID Comparison

Compare ARMP & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • AUID
  • Stock Information
  • Founded
  • ARMP N/A
  • AUID 2009
  • Country
  • ARMP United States
  • AUID United States
  • Employees
  • ARMP N/A
  • AUID N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • AUID Computer Software: Prepackaged Software
  • Sector
  • ARMP Health Care
  • AUID Technology
  • Exchange
  • ARMP Nasdaq
  • AUID Nasdaq
  • Market Cap
  • ARMP 52.1M
  • AUID 51.8M
  • IPO Year
  • ARMP N/A
  • AUID N/A
  • Fundamental
  • Price
  • ARMP $1.23
  • AUID $8.07
  • Analyst Decision
  • ARMP Strong Buy
  • AUID
  • Analyst Count
  • ARMP 1
  • AUID 0
  • Target Price
  • ARMP $7.00
  • AUID N/A
  • AVG Volume (30 Days)
  • ARMP 30.3K
  • AUID 318.1K
  • Earning Date
  • ARMP 05-06-2025
  • AUID 05-14-2025
  • Dividend Yield
  • ARMP N/A
  • AUID N/A
  • EPS Growth
  • ARMP N/A
  • AUID N/A
  • EPS
  • ARMP N/A
  • AUID N/A
  • Revenue
  • ARMP $5,174,000.00
  • AUID $886,485.00
  • Revenue This Year
  • ARMP $8.43
  • AUID N/A
  • Revenue Next Year
  • ARMP N/A
  • AUID N/A
  • P/E Ratio
  • ARMP N/A
  • AUID N/A
  • Revenue Growth
  • ARMP 14.24
  • AUID 365.86
  • 52 Week Low
  • ARMP $0.90
  • AUID $4.01
  • 52 Week High
  • ARMP $3.45
  • AUID $12.31
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 39.22
  • AUID 65.88
  • Support Level
  • ARMP $1.11
  • AUID $5.00
  • Resistance Level
  • ARMP $1.30
  • AUID $8.50
  • Average True Range (ATR)
  • ARMP 0.14
  • AUID 1.12
  • MACD
  • ARMP 0.01
  • AUID 0.29
  • Stochastic Oscillator
  • ARMP 42.86
  • AUID 75.11

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

Share on Social Networks: